載入...
Safety and effectiveness of alectinib in a real‐world surveillance study in patients with ALK‐positive non–small‐cell lung cancer in Japan
We conducted a large‐scale surveillance study as a post–marketing commitment to investigate the safety and effectiveness of alectinib in patients with ALK‐positive non–small‐cell lung cancer (NSCLC) in Japan. Patients receiving 300 mg twice‐daily alectinib (September 2014 to June 2015) were monitore...
Na minha lista:
| 發表在: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6447840/ https://ncbi.nlm.nih.gov/pubmed/30776174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13977 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|